• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Immunol . Human naïve B cells recognize prepandemic influenza virus hemagglutinins

tetano

Editor, Senior Moderator
Sci Immunol


. 2025 Jan 24;10(103):eado9572.
doi: 10.1126/sciimmunol.ado9572. Epub 2025 Jan 24. Human naïve B cells recognize prepandemic influenza virus hemagglutinins

Jared Feldman[SUP] 1 [/SUP], Ana Sofia Ferreira Ramos[SUP] 2 [/SUP], Mya Vu[SUP] 1 [/SUP], Daniel P Maurer[SUP] 1 [/SUP], Victoria C Rosado[SUP] 1 [/SUP], Daniel Lingwood[SUP] 1 [/SUP], Goran Bajic[SUP] 2 [/SUP], Aaron G Schmidt[SUP] 1 3 [/SUP]



Affiliations
Abstract

Understanding the naïve B cell repertoire and its specificity for potential zoonotic threats, such as the highly pathogenic avian influenza (HPAI) H5Nx viruses, may allow prediction of infection- or vaccine-specific responses. However, this naïve repertoire and the possibility to respond to emerging, prepandemic viruses are largely undetermined. Here, we profiled naïve B cell reactivity against a prototypical HPAI H5 hemagglutinin (HA), the major target of antibody responses. We found that the frequency of H5-specific human naïve B cells targeting the HA "head" domain was increased relative to cross-reactive B cells to a circulating seasonal H1N1 strain. We classified the isolated monoclonal antibodies (mAbs) by the HA epitopes engaged and found that selected mAbs neutralized H5N1 at germline. We determined a cryo-electron microscopic structure of one mAb in complex with H5 HA to define its epitope. Our study defines the naïve human B cell repertoire recognizing a potentially zoonotic HPAI.


 
Back
Top